Top View
- LJMU Research Online
- Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
- (12) United States Patent (Lo) Patent No.: US 8,480,637 B2
- Assessing the Potential Toxicity of MK-801 and Remacemide: Chronic Exposure in Juvenile Rhesus Monkeys
- Marrakesh Agreement Establishing the World Trade Organization
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- WO 2015/171770 Al 12 November 2015 (12.11.2015) P O P C T
- From PCP to MXE: a Comprehensive Review of the Non-Medical Use of Dissociative Drugs Hamilton Morrisa and Jason Wallachb*
- Customs Tariff - Schedule
- Journal.Pone.0157021
- (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
- Pharmacological Perioperative Brain Neuroprotection: a Qualitative Review of Randomized Clinical Trials
- Preclinical Investigations with Remacemide Hydrochloride
- TAR/W/87 21 Juin 1993 DOUANIERS ET LE COMMERCE Distribution Limitée
- Center for Drug Information and Pharmacy Practice1, ABDA
- ( 12 ) Patent Application Publication ( 10 ) Pub . No .: US 2020/0215078 A1
- Wo 2007/044693 A2
- PDF Hosted at the Radboud Repository of the Radboud University Nijmegen
- Pjp5'2003.Vp:Corelventura
- EEG Gamma Power Changes Following Administration of NMDA
- Therapeutic and Toxic Blood Concentrations of More Than 1100 Drugs and Other Xenobiotics
- Predictive Value of Parkinsonian Primates in Pharmacologic Studies: a Comparison Between the Macaque, Marmoset, and Squirrel Monkey S
- Lack of Pharmacokinetic Interaction Between Remacemide Hydrochloride and Sodium Valproate in Epileptic Patients
- (12) United States Patent (10) Patent No.: US 8,944,055 B2 Gibbins Et Al
- (12) United States Patent (10) Patent No.: US 8,480,637 B2 Ferrari Et Al
- Poster Session Iiiwednesday, December 10, 2014
- Neuronal Death Enhanced by N-Methyl-D- Aspartate Antagonists
- Pharmaceutical Appendix to the Tariff Schedule 2
- Neurobiological Factors Modulating H1-Antihistamine Induced Cognitive Impairment
- (12) Patent Application Publication (10) Pub. No.: US 2011/0054038A1 Glozman (43) Pub
- Adverse Motor Effects Induced by Antiepileptic Drugs
- Harmonized Tariff Schedule of the United States (2006) (Rev
- List of Chemical Weapons Spirits for MD Abacination, Abbadon, Acacia
- 1111111111111111111Imnumu
- Differential Effects of Two NMDA Receptor Antagonists on Cognitive–Behavioral Performance in Young Nonhuman Primates II
- The Effect of High and Low Antiepileptic Drug Dosage on Simulated Driving Performance in Person's with Seizures
- Ionotropic Glutamate Receptors in Epilepsy: a Review Focusing on AMPA and NMDA Receptors
- Monotherapy Antiepileptic Drug Trials in Patients Undergoing Presurgical Assessment: Methodological Problems and Possibilities
- Accepted Author Manuscript
- (12) United States Patent (10) Patent No.: US 8,729,070 B2 Glozman (45) Date of Patent: May 20, 2014
- Differential Effects of Two NMDA Receptor Antagonists on Cognitive– Behavioral Development in Nonhuman Primates I$
- On the Resilience of the Dark Net Market Ecosystem to Law Enforcement Intervention
- Veyres N, Hamadjida A, Huot P. Predictive Value of Parkinsonian Primates in Pharmacological Studies, a Comparison Between the Macaque, Marmoset and Squirrel Monkey
- Overview Lifestyle Issues with Epilepsy Antiepileptic Drugs (Aeds)
- Early Life Exposure to Extended General Anesthesia with Isoflurane